Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial In Stage III/IV Malignant Melanoma Using Autologous Dendritic Cells Loaded With Tumor Cell Lysates And Low Doses Of Proleukin

NCT06152367 is registered in ClinicalTrials.gov with University of Chile as lead sponsor.

NCT NCT06152367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06152367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial In Stage III/IV Malignant Melanoma Using Autologous Dendritic Cells Loaded With Tumor Cell Lysates And Low Doses Of Proleukin
Lead sponsor
University of Chile
Phase
Phase 1/2
Overall status
Completed
Start date
January 30, 2001
Completion date
October 9, 2004
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii malignant melanoma of skin ajcc v6, stage iv malignant melanoma of skin